Venom phospholipase A2-induced impairment of glutamate uptake: An indirect and nonselective effect related to phospholipid hydrolysis

Journal of Neuroscience Research

Volumn 51, Issue 3, 1998, Pages 349-359

  Dorandeu, F ^a,c   Antier, D ^a,b   Pernot Marino, I ^a   Lapeyre, P ^a   Lallement, G ^a  

^a CENTRE DE RECHERCHES   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c CRSSA   (France)

Author keywords

Arac hidonic acid; Choline; Dopamine; Glutamate; Hippocampus; Paradoxin; PLA2; Reuptake; Striatum

Indexed keywords

ARACHIDONIC ACID; CHOLINE; FATTY ACID; GLUTAMIC ACID; INDOMETACIN; LIPOXYGENASE; NEUROTOXIN; NORDIHYDROGUAIARETIC ACID; PHOSPHOLIPASE A2; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN SYNTHASE; DOPAMINE; FISH VENOM; LIPOXYGENASE INHIBITOR; PARDAXIN; PHOSPHOLIPASE A; PHOSPHOLIPID; PROSTAGLANDIN SYNTHASE INHIBITOR; SNAKE VENOM;

AMINO ACID TRANSPORT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HYDROLYSIS; MALE; NEUROTRANSMISSION; NONHUMAN; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; RAT; ANIMAL; CORPUS STRIATUM; DRUG EFFECT; ENZYMOLOGY; METABOLISM; WISTAR RAT;

ANIMALS; ARACHIDONIC ACID; CHOLINE; CORPUS STRIATUM; CYCLOOXYGENASE INHIBITORS; DOPAMINE; ELAPID VENOMS; FATTY ACIDS; FISH VENOMS; GLUTAMIC ACID; HIPPOCAMPUS; HYDROLYSIS; LIPOXYGENASE INHIBITORS; MALE; PHOSPHOLIPASES A; PHOSPHOLIPIDS; RATS; RATS, WISTAR;

EID: 0031987319     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980201)51:3<349::AID-JNR8>3.0.CO;2-G     Document Type: Article

References (63)

1. Agostinho P, Duarte CB, Oliveira CR (1997): Impairment of excitatory amino acid transporter activity by oxidative stress conditions in retinal cells: Effect of antioxidants. FASEB J 11:154-163.
2. Bazan NG (1989): Arachidonic acid in the modulation of excitable membrane function and at the onset of brain damage. Ann NY Acad Sci 559:1-16.
3. Bazan NG, Rodriguez De Turco EB, Geoffrey A M(1995): Mediators of injury in neurotrauma: intracellular signal transduction and gene expression. J Neurotrauma 12:791-814.
4. Boksa P, Mykita S, Collier B (1988): Arachidonic acid inhibits choline uptake and depletes acetylcholine content in rat cerebral cortical synaptosomes. J Neurochem 50:1309-1318.
5. 2 modulates different subtypes of excitatory amino acid receptors: Autoradiographic evidence. J Neurochem 60:236-245.
6. 2-induced neurotoxicity in vitro and in vivo in rats. Brain Res 693:101-111.
7. Delot E, Bon C (1993): Model for the interaction of crotoxin, a phospholipase A2 neurotoxin, with presynaptic membranes. Biochemistry 32:10708-10713.
8. Dennis EA (1994): Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem 269:13057-13060.
9. Dowdall MJ, Fohlman JP, Eaker D (1977): Inhibition of high-affinity choline transport in peripheral cholinergic endings by presynaptic snake venom neurotoxins. Nature 269:700-702.
10. Dowdall MJ, Fretten P, Culliford PG (1986): Action of phospholipase neurotoxins on Torpedo synaptosomes: Changes in membrane potential and phosphoglyceride composition. In I. Hanin (ed): "Dynamics of Cholinergic Function." New York: Plenum Press, pp 1187-1201.
11. Edstrom A, Briggman M, Ekstrom PAR (1996): Phospholipase A2 activity is required for regeneration of sensory axons in cultured adult sciatic nerves. J Neurosci Res 43:183-189.
12. Erecinska M, Silver IA (1990): Metabolism and role of glutamate in mammalian brain. Prog Neurobiol 35:245-296.
13. Fletcher JE, Jiang MS (1995): Presynaptically acting snake venom phospholipase A2 enzymes attack unique substrates. Toxicon 33:1565-1576.
14. Fletcher JE, Jiang MS, Middlebrook JL (1995a): Antibodies having markedly different effects on enzymatic activity and induction of acetylcholine release by two presynaptically-acting phospholipase A2 neurotoxins. Biochem Pharmacol 49:381-388.
15. Fletcher JE, Storella RJ, Jiang MS (1995b): Bovine serum albumin does not completely block synaptosomal cholinergic activities of presynaptically acting snake venom phospholipase A2 enzymes. Toxicon 33:1051-1060.
16. Fohlman J, Eaker D, Karlsson E, Thesleff S (1976): Taipoxin, an extremely potent presynaptic neurotoxin from the venom of the Australian snake taipan (Oxyuranus s. scutellatus). Isolation, characterization, quaternary structure and pharmacological properties. Eur J Biochem 68:457-469.
17. Fohlman J, Eaker D, Dowdall MJ, Lullmann-Rauch R, Sjodin T, Leander S (1979): Chemical modification of taipoxin and the consequences for phospholipase activity, pathophysiology. and inhibition of high-affinity choline uptake. Eur J Biochem 94:531-540.
18. Fossier P, Lambeau G, Lazdunski M, Baux G (1995): Inhibition of ACh release at an Aplysia synapse by neurotoxic phospholipases A2: Specific receptors and mechanisms of action. J Physiol (London) 489:29-10.
19. Gandolfo G, Lambeau G, Lazdunski M, Gottesmann C (1996): Effects on behaviour and EEG of single chain phospholipases A2 from snake and bee venoms injected into rat brain: Search for a functional antagonism. Pharmacol Toxicol 78:341-347.
20. Halliwell JV, Tse CK, Spokes JW, Othman I, Dolly JO (1982): Biochemical and electrophysiological demonstrations of the actions of beta-bungarotoxin on synapses in brain. J Neurochem 39:543-550.
21. Kanai Y, Smith CP, Hediger MA (1993): The elusive transporters with a high affinity for glutamate. Trends Neurosci 16:365-370.
22. Katayama Y, Kawamata T, Maeda T, Ishikawa K, Tsubokawa T (1994): Inhibition of the early phase of free fatty acid liberation during cerebral ischemia by excitatory amino acid antagonist administered by microdialysis. Brain Res 635:331-334.
23. Katsuki H, Okuda S (1995): Arachidonic acid as a neurotoxic and neurotrophic substance. Prog Neurobiol 46:607-636.
24. +, prevent arachidonic acid toxicity on neuronal cultures. Neuroreport 6:1101-1104.
25. Katsura K, Rodriguez de Turco EB, Folbergrova J, Bazan NG, Siesjo BK (1993): Coupling among energy failure, loss of ion homeostasis, and phospholipase A2 and C activation during ischemia. J Neurochem 61:1677-1684.
26. Khan WA, Blobe GC, Hannun YA (1995): Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C. Cell Signal 7:171-184.
27. Killinger S, Li Y, Balcar VJ (1995): Sensitivity of the binding sites on glutamate transporters to neurotoxic agents. Neuroreport 6:1290-1292.
28. Kolko M, DeCoster MA, Rodriguez de Turco EB, Bazan NG (1996): Synergy by secretory phospholipase A2 and glutamate on inducing cell death and sustained arachidonic acid metabolic changes in primary cortical neuronal cultures. J Biol Chem 271:32722-32728.
29. Kristofikova Z, Klaschka J (1997): In vitro effects of arachidonic and L-glutamic acids on the high-affinity choline transport in rat hippocampus. Neurochem Res 22:67-73.
30. Lambeau G, Barhanin J, Schweitz H, Qar J, Lazdunski M (1989): Identification and properties of very high affinity brain membrane-binding sites for a neurotoxic phospholipase from the taipan venom. J Biol Chem 264:11503-11510.
31. Lauritzen I, Heurteaux C, Lazdunski M (1994): Expression of group II phospholipase A2 in rat brain after severe forebrain ischemia and in endotoxic shock. Brain Res 651:353-356.
32. Levi G, Raiteri M (1993): Carrier-mediated release of neurotransmitters. Trends Neurosci 16:415-419.
33. L'hirondel M, Chéramy A, Godeheu G, Glowinski J (1995): Effects of arachidonic acid on dopamine synthesis, spontaneous release, and uptake in striatal synaptosomes from the rat. J Neurochem 64:1406-1409.
34. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951): Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
35. Massicotte G, Baudry M (1990): Modulation of DL-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA)/quisqualate receptors by phospholipase A2 treatment. Neurosci Lett 118:245-248.
36. Massicotte G, Vanderklish P, Lynch G, Baudry M (1991): Modulation of DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/quisqualate receptors by phospholipase A2: A necessary step in long-term potentiation? Proc Natl Acad Sci USA 88:1893-1897.
37. Massicotte G, Bernard J, Baudry M (1992): Postnatal changes in AMPA receptor regulation by phospholipase A2 treatment of synaptic membranes: Temporally differential effects on agonist and antagonist binding. Brain Res Dev Brain Res 66:203-208.
38. Matsuzawa A, Murakami M, Atsumi G, Imai K, Prados P, Inoue K, Kudo I (1996): Release of secretory phospholipase A(2) from rat neuronal cells and its possible function in the regulation of catecholamine secretion. Biochem J 318:701-709.
39. Meldrum BS (1993): The role of glutamate in epilepsy and other CNS disorders. Neurology 44:S14-S23.
40. Meves H (1994): Modulation of ion channels by arachidonic acid. Prog Neurobiol 43:175-186.
41. Mollier P, Brochier G, Morot Gaudry-Talarmain Y (1990): The action of notexin from tiger snake venom (Notechis scutatus scutatus) on acetylcholine release and compartmentation in synaptosomes from electric organ of Torpedo marmorata. Toxicon 28:1039-1052.
42. Morrison J, Pearn J, Covacevich J, Tanner C, Coulter A (1983-1984): Studies on the venom of Oxyuranus microlepidotus. Clin Toxicol 21:373-385.
43. Ng RH, Howard BD (1978): Deenergization of nerve terminals by beta-bungarotoxin. Biochemistry 17:4978-4986.
44. Ng RH, Howard BD (1981): Inhibition by neurotoxic phospholipases A2 of synaptosomal uptake of gamma-aminobutyric acid. J Neurochem 36:310-312.
45. Nicholls DG (1993): The glutamatergic nerve terminal. Eur J Biochem 212:613-631.
46. Nicholls D, Snelling R, Dolly O (1985): Bioenergetic actions of beta-bungarotoxin, dendrotoxin and bee-venom phospholipase A2 on guinea-pig synaptosomes. Biochem J 229:653-562.
47. O'Regan MH, Smith-Barbour M, Perkins LM, Phillis JW (1995): A possible role for phospholipases in the release of neurotransmitter amino acids from ischemic rat cerebral cortex. Neurosci Lett 185:191-194.
48. O'Regan MH, Alix S, Woodbury DJ (1996): Phospholipase A2-evoked destabilization of planar lipid membranes. Neurosci Lett 202: 201-203.
49. Paxinos G, Watson C (1982): "The Rat Brain in Stereotaxic Coordinates." New York: Academic Press Inc.
50. Saltarelli MD, Yamada K, Coyle JT (1990): Phospholipase A2 and 3H-hemicholinium-3 binding sites in rat brain: A potential second-messenger role for fatty acids in the regulation of high-affinity choline uptake. J Neurosci 10:62-72.
51. Smith CCT, Bradford HF, Thompson EJ, MacDermot J (1980): Actions of beta-bungarotoxin on amino acid transmitter release. J Neurochem 34:487-494.
52. Tojo H, Ono T, Okamoto M (1993): Reverse-phase high-performance liquid Chromatographic assay of phospholipases: Application of spectrophotometric detection to rat phospholipase A2 isozymes. J Lipid Res 34:837-844.
53. Trotti D, Volterra A, Lehre KP, Rossi D, Gjesdal O, Racagni G, Danbolt NC (1995): Arachidonic acid inhibits a purified and reconstituted glutamate transporter directly from the water phase and not via the phospholipid membrane. J Biol Chem 270:9890-9895.
54. Tzeng MC, Yen CH, Hseu MJ, Tseng CC, Tsai MD, Dupureur CM (1995): Binding proteins on synaptic membranes for crotoxin and taipoxin, two phospholipases A2 with neurotoxicity. Toxicon 33:451-457.
55. Volterra A, Trotti D, Cassutti P, Tromba C, Salvaggio A, Melcangi RC, Racagni G (1992): High sensitivity of glutamate uptake to extracellular free arachidonic acid levels in rat cortical synaptosomes and astrocytes. J Neurochem 59:600-606.
56. Volterra A, Trotti D, Racagni G (1994a): Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and additive mechanisms. Mol Pharmacol 46:986-992.
57. Volterra A, Trotti D, Tromba C, Floridi S, Racagni G (1994b): Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J Neurosci 14:2924-2932.
58. Wernicke JF, Oberjat T, Howard BD (1974): Beta-neurotoxin reduces neurotransmitter storage in brain synapses. J Neurochem 22:781-788.
59. Wernicke JF, Vanker AD, Howard BD (1975): The mechanism of action of beta-bungarotoxin. J Neurochem 25:483-496.
60. Yamada K, Saltarelli MD, Coyle JT (1988): Involvement of phospholipase A2 in the regulation of [3H]hemicholinium-3 binding. Biochem Pharmacol 37:4367-4373.
61. + ATPase activity in rat brain synaptosomes. Toxicol Appl Pharmacol 109:207-218.
62. Zanchin G, De Boni A, Lauria G, Maggioni F, Rossi P, Villacara A (1995): Synaptosomal glutamate uptake in a model of experimental cerebral ischemia. Neurochem Res 20:195-199.
63. Zhang L, Reith MEA (1996): Regulation of the functional activity of the human dopamine transporter by the arachidonic acid pathway. Eur J Pharmacol 315:345-354.